You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 10, 2024

CLINICAL TRIALS PROFILE FOR IXEKIZUMAB

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ixekizumab

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00966875 ↗	A Study in Patients With Rheumatoid Arthritis	Completed	Eli Lilly and Company	Phase 2	2009-08-01	The primary purpose of the study is to help answer the following research questions, and not to provide treatment for Rheumatoid Arthritis (RA): - The safety of LY2439821 and any side effects that might be associated with it. - Whether LY2439821 can help participants with active RA. - How much LY2439821 should be given to participants.
NCT01107457 ↗	A Study in Participants With Moderate to Severe Psoriasis	Completed	Eli Lilly and Company	Phase 2	2010-04-01	The primary purpose for this study is to help answer the following research questions - The safety of ixekizumab (LY2439821) and any side effects that might be associated with it. - Whether ixekizumab can help participants with Psoriasis. - How much ixekizumab should be given to participants.
NCT01597245 ↗	A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)	Completed	Eli Lilly and Company	Phase 3	2012-05-18	This study will assess the safety and efficacy of ixekizumab (LY2439821) compared to etanercept and placebo in participants with moderate to severe chronic plaque psoriasis.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ixekizumab

Condition Name

Chart
Table

Condition Name for ixekizumab
Intervention	Trials
Plaque Psoriasis	10
Psoriasis	10
Psoriatic Arthritis	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ixekizumab
Intervention	Trials
Psoriasis	22
Arthritis, Psoriatic	8
Arthritis	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ixekizumab

Trials by Country

Map
Table

Trials by Country for ixekizumab
Location	Trials
United States	389
United Kingdom	47
Canada	41
Germany	39
China	32
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ixekizumab
Location	Trials
Florida	21
Texas	19
California	19
New York	17
North Carolina	17
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ixekizumab

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ixekizumab
Clinical Trial Phase	Trials
Phase 4	8
Phase 3	24
Phase 2	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ixekizumab
Clinical Trial Phase	Trials
Completed	30
Recruiting	6
Not yet recruiting	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ixekizumab

Sponsor Name

Chart
Table

Sponsor Name for ixekizumab
Sponsor	Trials
Eli Lilly and Company	35
Icahn School of Medicine at Mount Sinai	2
AbbVie	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ixekizumab
Sponsor	Trials
Industry	40
Other	25
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.